B of A Securities analyst Geoff Meacham upgrades Gilead Sciences (NASDAQ:GILD) from Neutral to Buy and raises the price target from $88 to $95.
B of A Securities analyst Geoff Meacham upgrades Gilead Sciences (NASDAQ:GILD) from Neutral to Buy and raises the price target from $88 to $95.